Primary Biliary Cholangitis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MIRM | B | Mirum Pharmaceuticals, Inc. | 0.32 | |
THAR | D | Tharimmune, Inc. | 8.80 | |
GNFT | F | GENFIT S.A. | -1.62 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Primary Biliary Cholangitis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
HRTS | D | Tema Cardiovascular and Metabolic ETF | 2.6 | |
BBP | C | BioShares Biotechnology Products Fund | 2.41 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 1.47 | |
ILDR | B | First Trust Innovation Leaders ETF | 0.67 | |
FYC | B | First Trust Small Cap Growth AlphaDEX Fund | 0.57 |
Compare ETFs
Related Industries:
Biotechnology
- Primary Biliary Cholangitis
Primary Biliary Cholangitis (PBC) is a chronic, progressive autoimmune liver disease that affects the small bile ducts in the liver. It is caused by an immune system attack on the bile ducts, leading to inflammation, scarring, and eventual destruction of the ducts. Symptoms of PBC include fatigue, itching, jaundice, and abdominal pain. Treatment typically involves medications to reduce inflammation and slow the progression of the disease.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles